His main research concerns Surgery, Internal medicine, Colorectal cancer, Cancer and Survival rate. Surgery is closely attributed to Hyperthermic intraperitoneal chemotherapy in his work. David L. Morris combines subjects such as Gastroenterology, Endocrinology and Oncology with his study of Internal medicine.
His study in Colorectal cancer is interdisciplinary in nature, drawing from both Percutaneous, Radiology, Radiofrequency ablation, Metastasis and Lung. His Cancer study combines topics from a wide range of disciplines, such as Laparoscopy and Immunology. David L. Morris has included themes like Prognostic variable, Prospective cohort study, Retrospective cohort study, Hepatectomy and Survival analysis in his Survival rate study.
His primary scientific interests are in Surgery, Internal medicine, Colorectal cancer, Gastroenterology and Chemotherapy. His studies in Surgery integrate themes in fields like Hyperthermic intraperitoneal chemotherapy and Cytoreductive surgery. The study incorporates disciplines such as Peritoneal Cancer Index, Pseudomyxoma peritonei and Peritoneal mesothelioma in addition to Hyperthermic intraperitoneal chemotherapy.
The various areas that David L. Morris examines in his Internal medicine study include Endocrinology and Oncology. His work is dedicated to discovering how Colorectal cancer, Radiology are connected with Lung and other disciplines. His biological study spans a wide range of topics, including Surgical oncology and Retrospective cohort study.
David L. Morris mostly deals with Surgery, Internal medicine, Hyperthermic intraperitoneal chemotherapy, Cytoreductive surgery and Colorectal cancer. He focuses mostly in the field of Surgery, narrowing it down to matters related to Peritonectomy and, in some cases, Radiology. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology.
David L. Morris interconnects Incidence, Peritoneal Cancer Index, Peritoneal surface, Pseudomyxoma peritonei and Surgical oncology in the investigation of issues within Hyperthermic intraperitoneal chemotherapy. His study explores the link between Cytoreductive surgery and topics such as Retrospective cohort study that cross with problems in Peritoneal Neoplasm and Surgical team. His Colorectal cancer research includes themes of Carcinoembryonic antigen and Resection.
David L. Morris mainly focuses on Internal medicine, Surgery, Hyperthermic intraperitoneal chemotherapy, Colorectal cancer and Conventional PCI. His research in Internal medicine intersects with topics in Gastroenterology and Oncology. David L. Morris has researched Oncology in several fields, including Combined Modality Therapy and Peritoneal carcinomatosis.
His work carried out in the field of Surgery brings together such families of science as Cytoreductive surgery, Peritoneal Cancer Index and Pseudomyxoma peritonei. His Hyperthermic intraperitoneal chemotherapy research is multidisciplinary, incorporating perspectives in Chemotherapy, Peritoneal mesothelioma, Peritoneal surface, Confidence interval and Surgical oncology. His work deals with themes such as Hepatocellular carcinoma, Carcinoembryonic antigen, Carcinoma and Hazard ratio, which intersect with Colorectal cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Terence C. Chua;Brendan J. Moran;Paul H. Sugarbaker;Edward A. Levine.
Journal of Clinical Oncology (2012)
Tissue surface treatment apparatus and method
David L. Morris;Steven A. Daniel;Daniel J. Balbierz.
Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?: A Systematic Review of Morbidity and Mortality
Terence C. Chua;Tristan D. Yan;Akshat Saxena;David L. Morris.
Annals of Surgery (2009)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan;Marcello Deraco;Dario Baratti;Shigeki Kusamura.
Journal of Clinical Oncology (2009)
Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus
James Bentham;David L. Morris;Deborah S. Cunninghame Graham;Christopher L. Pinder.
Nature Genetics (2015)
Recent advances in understanding leptin signaling and leptin resistance
David L. Morris;Liangyou Rui.
American Journal of Physiology-endocrinology and Metabolism (2009)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement
J. Esquivel;R. Sticca;P. Sugarbaker;E. Levine.
Annals of Surgical Oncology (2007)
A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer
Tristan D. Yan;Tristan D. Yan;Deborah Black;Paul H. Sugarbaker;Jacqui Zhu.
Annals of Surgical Oncology (2007)
Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
Julie King;Richard Quinn;Derek M. Glenn;Julia Janssen.
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours.
Ashvin Paramanathan;Akshat Saxena;David Lawson Morris.
Surgical Oncology-oxford (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: